Lung & Bone Biopsy
- A percutaneous biopsy is image-guided pickpocketing: we slide a needle to a target, grab a sample, and leave, watching the whole way on CT (or ultrasound for shallow targets).
- Lung biopsy's signature complication is pneumothorax — air leaking into the chest because we crossed aerated lung. Some bleed (hemoptysis) too.
- Bone biopsy's challenge is the opposite: getting through hard cortex to the target, often with a drill-like coaxial system.
- Two sampling styles: FNA (a thin needle for cells) and core (a wider needle for an intact tissue cylinder, so the pathologist sees architecture).
- The whole game is planning a safe path: shortest route, fewest things to puncture, avoiding vessels, fissures, and bullae.
Somewhere a nodule is sitting in a lung, refusing to confess whether it's cancer, infection, or absolutely nothing. The pictures can only narrow it down so far. Eventually someone has to walk a needle in there and take a piece — politely, precisely, and ideally without popping the lung on the way. That's the percutaneous biopsy, and it's one of the most satisfying things in image-guided procedures.
What we're actually trying to do
The job is simple to say and fussy to do: get a representative sample of a lesion without an open operation. We do it through the skin (percutaneous, "through the skin") using imaging as live GPS. Ultrasound for things we can see from the surface; CT for almost everything deep, because CT shows the needle tip and the target in the same crisp slice.
Think of it like reaching into a claw machine where the glass is opaque and the prize is the size of a grape. You don't get to look directly — you trust the screen, advance a little, re-check, advance a little more.
FNA vs core: cells or a real tissue plug
Two flavors of needle, and the choice matters.
| Technique | What you get | Good for |
|---|---|---|
| Fine-needle aspiration (FNA) | Loose cells smeared on a slide | "Is this cancer, yes or no?", cytology, sometimes infection |
| Core needle biopsy | An intact cylinder of tissue (architecture preserved) | Subtyping tumors, lymphoma workup, anything needing tissue structure |
FNA is the quick yes/no. Core is the full interview — pathologists love it because they can see how the cells are arranged, not just that they exist. Many modern targets (especially when molecular testing is needed) push us toward cores.
A coaxial system is the trick that makes multiple samples humane: one outer guide needle parks at the lesion, and you pass the sampling needle in and out through it. One puncture, several cores.
Lung biopsy: mind the air
Lung is mostly air, and air is the enemy here. To reach a solitary pulmonary nodule, the needle usually has to cross aerated lung — and every crossing risks letting air escape into the pleural space, which is exactly the recipe for a pneumothorax.
Planning is everything. We pick the shortest path through lung, avoid crossing a fissure if we can (crossing pleura twice doubles the trouble), and steer well clear of bullae and big vessels. Patient position and breathing matter too — the target moves with every breath, so we sample on a consistent breath-hold.
Crossing a fissure means puncturing visceral pleura twice instead of once — markedly higher pneumothorax risk. If a path crosses a fissure, look hard for a better angle before committing.
The other lung-specific issue is bleeding: a little blood-tinged cough (hemoptysis) is common and usually self-limited, but it's why we keep the puncture count down and avoid raking the needle around.
Pneumothorax is the expected price of admission for lung biopsy, and most are small and watched. But a tension pneumothorax or air embolism — rare as it is — is a genuine emergency. The patient stays monitored, and a post-procedure chest image is standard to catch a growing pneumothorax before it declares itself loudly.
Bone biopsy: the opposite problem
If lung biopsy is about too much give, bone biopsy is about not enough. The target is often locked behind dense cortical bone, so part of the skill is getting through that shell to reach the bone lesion inside.
The tools reflect it: bone biopsy needles are sturdier, sometimes battery-powered drills, with a trephine (a hollow coring bit) that bites out a cylinder of bone. Picture coring an apple — except the apple is a femur and you're watching on CT.
A practical rule shapes how we approach a suspected primary bone tumor: the biopsy tract can be seeded with tumor cells and may need to be removed at definitive surgery. So whenever the lesion might be a primary sarcoma, the path should be planned with the surgeon, so the tract sits within the eventual resection.
For a soft, lytic, destructive lesion you may only need a soft-tissue-style core through the thin or absent cortex. For a sclerotic, dense lesion you'll need the drill. Reading the lesion first tells you which weapon to bring.
Before, during, and after
Before anyone touches a needle, we check the boring-but-critical stuff: coagulation status and any blood thinners, and a clear consent and periprocedural plan. A biopsy of an easily-reached mass is low drama; a deep lung nodule next to a vessel is not, and the consent conversation should match.
During: local anesthetic, sterile technique, then the slow advance-and-check rhythm. Samples often get a quick on-site adequacy check so we know we actually captured lesion and not just the tissue next door.
After: pressure, observation, and imaging tuned to the site — a chest image after lung work, watching for the pneumothorax that may declare itself over the next couple of hours.
The throughline for both organs is the same unglamorous truth: a great biopsy is 80% planning the path and 20% pushing the needle. Pick the route that crosses the least trouble, sample enough to actually answer the question, and the lesion finally has to tell you what it is.